Publications 2019

  1. Zhang, Yang L, Shergis J, Zhang L, Zhang AL, Guo X, et al. Chinese herbal medicine for diabetic kidney disease: a systematic review and meta-analysis of randomised placebo-controlled trials. BMJ open. 2019;9(4):e025653.
  2. Young C, Craig JC, Clapham K, Banks S, Williamson A. The prevalence and protective factors for resilience in adolescent Aboriginal Australians living in urban areas: a cross-sectional study. Australian and New Zealand journal of public health. 2019;43(1):8-14.
  3. Wolley MJ, Hawley CM, Johnson DW, Marshall MR, Roberts MA. Incremental and twice weekly haemodialysis in Australia and New Zealand. Nephrology. 2019.
  4. Viecelli AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, Hawley CM, Badve SV, et al. Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial. Plos One. 2019;14(3):e0213274.
  5. van Zwieten A, Caldwell P, Howard K, Tong A, Craig JC, Alexander S, et al. NAV-KIDS(2) trial: protocol for a multi-centre, staggered randomised controlled trial of a patient navigator intervention in children with chronic kidney disease. BMC nephrology. 2019;20(1):134.
  6. Sypek MP, Dansie KB, Clayton P, Webster AC, McDonald S. Comparison of cause of death between Australian and New Zealand Dialysis and Transplant Registry and the Australian National Death Index. Nephrology. 2019;24(3):322-9.
  7. Sukul N, Zhao J, Fuller DS, Karaboyas A, Bieber B, Sloand JA, et al. Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPS. BMC nephrology. 2019;20(1):116.
  8. Smyth B, Krishnan AV, Gallagher M, Kiernan M, Snelling P, Hawley C, et al. Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol. 2019;9(1):bmjopen-2018-023736.
  9. Shen K, Vesey DA, Ellis RJ, Del Vecchio SJ, Cho Y, Teixeira-Pinto A, et al. GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma. Plos One. 2019;14(1):e0210246.
  10. Shanahan L, Le Leu R, Whittington T, Biddle A, McDonald S, Bennett PN, et al. Needle fear: A point prevalence survey of dialysis patients. Hemodialysis international International Symposium on Home Hemodialysis. 2019.
  11. See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR, et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney international. 2019;95(1):160-72.
  12. See EJ, Hedley J, Agar JWM, Hawley CM, Johnson DW, Kelly PJ, et al. Patient survival on haemodiafiltration and haemodialysis: a cohort study using the Australia and New Zealand Dialysis and Transplant Registry. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association – European Renal Association. 2019;34(2):326-38.
  13. See EJ, Hawley CM, Cho Y, Toussaint ND, Agar JW, Pascoe EM, et al. Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients. Nephrology. 2019;24(1):111-20.
  14. Saglimbene VM, Wong G, van Zwieten A, Palmer SC, Ruospo M, Natale P, et al. Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials. Clinical nutrition (Edinburgh, Scotland). 2019.
  15. Saglimbene VM, Wong G, Ruospo M, Palmer SC, Campbell K, Larsen VG, et al. Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study. Clinical nutrition (Edinburgh, Scotland). 2019;38(1):429-37.
  16. Ruderman I, Holt SG, Kirkland GS, Maslen S, Hawley CM, Oliver V, et al. Outcomes of cinacalcet withdrawal in Australian dialysis patients. Internal medicine journal. 2019;49(1):48-54.
  17. Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, et al. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2019;95(2):281-95.
  18. Rossignol P, Agarwal R, Canaud B, Charney A, Chatellier G, Craig JC, et al. Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints. European heart journal. 2019;40(11):880-6.
  19. Ralph AF, Butow P, Craig JC, Chapman JR, Gill JS, Kanellis J, et al. Clinicians’ attitudes and approaches to evaluating the potential living kidney donor-recipient relationship: An interview study. Nephrology. 2019;24(2):252-62.
  20. Nankivell BJ, P’Ng CH, Chapman JR. Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection? American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2019;19(1):132-44.
  21. Morton RL, Lioufas N, Dansie K, Palmer SC, Jose MD, Raj R, et al. Use of Patient-Reported Outcome Measures and Patient-Reported Experience Measures in Renal units in Australia and New Zealand: a Cross-sectional Survey Study. Nephrology. 2019.
  22. Manera KE, Johnson DW, Craig JC, Shen JI, Ruiz L, Wang AY, et al. Patient and Caregiver Priorities for Outcomes in Peritoneal Dialysis: Multinational Nominal Group Technique Study. Clin J Am Soc Nephrol. 2019;14(1):74-83.
  23. Manera KE, Johnson DW, Craig JC, Shen JI, Ruiz L, Wang AY, et al. Patient and Caregiver Priorities for Outcomes in Peritoneal Dialysis: Multinational Nominal Group Technique Study. Clin J Am Soc Nephrol. 2019;14(1):74-83.
  24. Mac K, Hedley J, Kelly PJ, Lee VW, Agar J, Hawley CM, et al. Effect of centre and patient related factors on uptake of haemodiafiltration in australia and new zealand: A Cohort study using anzdata. Nephrology. 2019.
  25. Lioufas N, Toussaint ND, Pedagogos E, Elder G, Badve SV, Pascoe E, et al. Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study. 2019;9(2):e024382.
  26. Lioufas N, Hawley CM, Cameron JD, Toussaint ND. Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review. International journal of hypertension. 2019;2019:9189362.
  27. Lim WH, Coates PT, Russ GR, Russell C, He B, Jaques B, et al. Weekend effect on early allograft outcome after kidney transplantation- a multi-centre cohort study. Transplant international : official journal of the European Society for Organ Transplantation. 2019;32(4):387-98.
  28. Li JW, Wong G, Li J, Gruenewald S, Chapman JR. Positional ischaemia of transplant kidney: A rare cause of early graft dysfunction. Journal of clinical ultrasound : JCU. 2019.
  29. Larkins NG, Teixeira-Pinto A, Craig JC. A narrative review of proteinuria and albuminuria as clinical biomarkers in children. Journal of paediatrics and child health. 2019;55(2):136-42.
  30. Larkins NG, Craig JC, Teixeira-Pinto A. A guide to missing data for the pediatric nephrologist. Pediatric nephrology. 2019;34(2):223-31.
  31. Lambie M, Teece L, Johnson DW, Petrie M, Mactier R, Solis-Trapala I, et al. Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association – European Renal Association. 2019.
  32. Kelly JT, Warner MM, Conley M, Reidlinger DP, Hoffmann T, Craig J, et al. Feasibility and acceptability of telehealth coaching to promote healthy eating in chronic kidney disease: a mixed-methods process evaluation. BMJ open. 2019;9(1):e024551.
  33. Ju A, Chow BY, Ralph AF, Howell M, Josephson MA, Ahn C, et al. Patient-reported outcome measures for life participation in kidney transplantation: A systematic review. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2019.
  34. Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, et al. Increasing access to integrated ESKD care as part of universal health coverage. Kidney international. 2019;95(4s):S1-s33.
  35. Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, et al. Increasing access to integrated ESKD care as part of universal health coverage. Kidney international. 2019;95(4s):S1-s33.
  36. Hanson CS, Sautenet B, Craig JC, Chapman JR, Knoll G, Reese PP, et al. Informative for Decision Making? The Spectrum and Consistency of Outcomes After Living Kidney Donation Reported in Trials and Observational Studies. Transplantation. 2019;103(2):284-90.
  37. Hanson CS, Gutman T, Craig JC, Bernays S, Raman G, Zhang Y, et al. Identifying Important Outcomes for Young People With CKD and Their Caregivers: A Nominal Group Technique Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019.
  38. Gutman T, Tong A, Howell M, Dansie K, Hawley CM, Craig JC, et al. Principles and strategies for involving patients in research in chronic kidney disease: report from national workshops. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association – European Renal Association. 2019.
  39. Francis A, Didsbury MS, van Zwieten A, Chen K, James LJ, Kim S, et al. Quality of life of children and adolescents with chronic kidney disease: a cross-sectional study. Archives of disease in childhood. 2019;104(2):134-40.
  40. Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, et al. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2019;95(2):268-80.
  41. Duncanson E, Dansie K, Gutman T, Tong A, Howell M, Jesudason S, et al. “Knowledge is power” – A framework for partnering with consumers in developing and delivering a scientific meeting in nephrology. Nephrology. 2019.
  42. Didsbury M, van Zwieten A, Chen K, James LJ, Francis A, Kim S, et al. The association between socioeconomic disadvantage and parent-rated health in children and adolescents with chronic kidney disease-the Kids with CKD (KCAD) study. Pediatric nephrology. 2019.
  43. Craig JC. Interpreting trial results-time for confidence and magnitude and not P values please. Kidney international. 2019;95(1):28-30.
  44. Cho Y, Sautenet B, Gutman T, Rangan G, Craig JC, Ong AC, et al. Identifying patient-important outcomes in polycystic kidney disease: an international nominal group technique study. Nephrology. 2019.
  45. Chan C, Combes G, Davies S, Finkelstein F, Firanek C, Gomez R, et al. Transition Between Different Renal Replacement Modalities: Gaps in Knowledge and Care-The Integrated Research Initiative. Perit Dial Int. 2019;39(1):4-12.
  46. Au EH, Chapman JR, Craig JC, Lim WH, Teixeira-Pinto A, Ullah S, et al. Overall and Site-Specific Cancer Mortality in Patients on Dialysis and after Kidney Transplant. J Am Soc Nephrol. 2019.

Back to Top